-
Cytokine Storm in Covid-19. How does Hemoperfusion...2023-01-17 -
Academic Perspective: Organ Crosstalk in Critical ...2023-01-17 -
Academic Perspective COVID-19 Experience Sharing -...2023-01-17 -
Clinical Practice Express: Hemoperfusion works in ...2023-01-17 -
Clinical Practice Express: COVID-19 Experience fro...2023-01-17 -
Focus on COVID-19 | Jafron hemoperfusion becomes a...2023-01-17 -
Cytokine storm control strategies in treating COVI...2023-01-17 -
Emergency Medical Assistance Signing Ceremony (Sau...2023-01-17 -
HA380/HA330 for 2019-nCoV Infection with ARDS2023-01-17
-
Cytokine Storm in Covid-19. How does Hemoperfusion work?2023-01-17
-
Academic Perspective: Organ Crosstalk in Critical illness2023-01-17
-
Academic Perspective COVID-19 Experience Sharing -- How to manage the critical i...2023-01-17
-
Clinical Practice Express: Hemoperfusion works in critical COVID-19 patient mana...2023-01-17
-
Clinical Practice Express: COVID-19 Experience from Italy and China2023-01-17
-
Focus on COVID-19 | Jafron hemoperfusion becomes a powerful weapon against coron...2023-01-17
-
Cytokine storm control strategies in treating COVID-19-Expert opinion from Prof....2023-01-17
-
Emergency Medical Assistance Signing Ceremony (Saudia Arabia-China)2023-01-17
-
HA380/HA330 for 2019-nCoV Infection with ARDS2023-01-17
Jafron Biomedical Co., Ltd.
Dirección: No. 98 Technology Six Road, High-tech Zone, Zhuhai City, China
Correo electrónico: customerservice@jafron.com
Sitio web: https://es.jafroninternational.com
Términos de uso｜Mapa del sitio｜ Aviso de cookies｜ Aviso de privacidad
Aviso de privacidad de la contratación
Línea directa disponible 24 horas al día, 7 días a la semana
© 2016 Jafron Biomedical Co., Ltd. Todos los derechos reservados.
